1. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion
   Caiqi Ma et al, 2018, Gastric Cancer CrossRef
2. The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertension
   null null et al, 2019, Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini CrossRef
3. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells
   Huai-Ching Tai et al, 2019, Marine Drugs CrossRef
4. Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
   Chuqi Wang et al, 2022, Frontiers in Oncology CrossRef
5. Angiogenesis and Lymphangiogenesis in Peritoneal Dialysis
   Guadalupe Tirma Gónzalez-Mateo et al, 2018, Aspects in Dialysis CrossRef
6. Stromal cells in breast cancer as a potential therapeutic target
   Samantha S. Dykes et al, 2018, Oncotarget CrossRef
7. PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor
   Chuanghua Luo et al, 2021, Cell Death & Disease CrossRef
8. Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
   Jianfang Huang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
9. Kallistatin Deficiency Induces the Oxidative Stress-Related Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells: A Novel Protagonist in Age-Related Macular Degeneration
   Gang Shen et al, 2023, Investigative Opthalmology & Visual Science CrossRef